<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03213093</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL16_0168</org_study_id>
    <nct_id>NCT03213093</nct_id>
  </id_info>
  <brief_title>Pressure and Diabetic Foot</brief_title>
  <acronym>PIV &amp; MPP</acronym>
  <official_title>Neurovascular Cutaneous Response to Pressure and Risk of Diabetic Foot Ulcer in Patients With Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Diabetic foot ulcer (DFU) is a worldwide burden in the management of patients with diabetes.
      Peripheral neuropathy has a key role in the physiopathology of DFU. Others factors as skin
      vulnerability to plantar pressure, glycation of skin protein, articular rigidity, vascular
      component and abnormal foot plantar pressure are also important to take into account. The aim
      of the study is to assess prospectively different factors involved in DFU pathogenesis
      notably the neurovascular response to non noxious pressure.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 2017</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>the rate of incidence of diabetic foot ulcer</measure>
    <time_frame>At any time during a 3 years follow-up</time_frame>
    <description>A diabetic foot ulcer is defined as a breakdown in the skin under malleolus</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Neurovascular response to pressure</measure>
    <time_frame>At the end of the 3-year follow-up</time_frame>
    <description>Receiver Operating Characteristic (ROC) analysis for neurovascular response to predict foot ulcer. Results are expressed in arbitrary unit.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Diabetes and Risk of Diabetic Foot Ulcer</condition>
  <arm_group>
    <arm_group_label>Diabetic patients with a risk of diabetic foot ulcer</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Measure of cutaneous microcirculation</intervention_name>
    <description>Measure of cutaneous microcirculation in response to a local application of pressure, to local heating and to the iontophoretic administration of acetylcholine</description>
    <arm_group_label>Diabetic patients with a risk of diabetic foot ulcer</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;18 years

          -  Type 2 diabetic subject

          -  Absence of active diabetic foot ulcer

          -  Patients &quot;Grade 1&quot; or &quot;Grade 2&quot; of the International Working Group on Diabetic Foot
             Risk Classification defined by:

          -  alteration of perception of Monofilament 10g at the level of the plantar arch for the
             &quot;grade 1&quot;

          -  alteration of perception of Monofilament 10g at the level of the plantar arch
             associated with foot deformity and / or an arteriopathy defined by the absence of
             perception of one of the two peripheral pulses for the &quot;grade 2&quot;

          -  Signature of consent to participate in the study

        Exclusion Criteria:

          -  Chronic alcoholism with usual consumption of at least 5 alcoholic drinks per day

          -  Pregnancy

          -  Congenital methemoglobinemia.

          -  Porphyria

          -  Skin injured on the tibia, whatever the lesion

          -  Recent major cardiovascular history (less than 3 months)

          -  Severe renal disease (serum creatinine&gt; 300 μmol.l-1)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Julien Vouillarmet</last_name>
    <phone>4-78-86-14-89</phone>
    <phone_ext>+33</phone_ext>
    <email>julien.vouillarmet@chu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>service d'endocrinologie, Centre Hospitalier Lyon Sud</name>
      <address>
        <city>Pierre-Bénite</city>
        <zip>69310</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Julien VOUILLARMET, MD</last_name>
      <email>julien.vouillarmet@chu-lyon.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 6, 2017</study_first_submitted>
  <study_first_submitted_qc>July 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 11, 2017</study_first_posted>
  <last_update_submitted>July 10, 2017</last_update_submitted>
  <last_update_submitted_qc>July 10, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">July 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Diabetes</keyword>
  <keyword>Diabetic Foot Ulcer</keyword>
  <keyword>Plantar pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Diabetic Foot</mesh_term>
    <mesh_term>Foot Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

